通化东宝：公司恩格列净前三季度销售额同比实现超100%增长

Group 1 - The core viewpoint of the article is that Tonghua Dongbao reported strong sales performance for its drug, Englitazone, in the first half of the year and the third quarter, with a year-on-year sales growth exceeding 100% in the first three quarters [1] Group 2 - The company responded to an investor inquiry on an interactive platform regarding the sales situation of Englitazone [1] - The sales figures indicate a significant increase, reflecting the company's strong market performance [1] - The report highlights the company's positive trajectory in sales, which may indicate potential growth opportunities in the pharmaceutical sector [1]